Health
State of Health Brazil results show China's Sinovac vaccine is just 50.4 percent effective against COVID-19
Just Earth News | @justearthnews | 14 Jan 2021, 09:56 pm Print
China COVID-19 Vaccine Brazilian clinical trials have unveiled that a COVID-19 vaccine developed by China's Sinovac has been found to be 50.4% effective, media reports said.
It shows the vaccine is significantly less effective than previous data suggested - barely over the 50% needed for regulatory approval, reports BBC.
The vaccine is one of the two which the Brazilian government has lined up.
Brazil is one of the worst-hit COVID-19 nations in the world.
Sinovac, a Beijing-based biopharmaceutical company, is behind CoronaVac, an inactivated vaccine. It works by using killed viral particles to expose the body's immune system to the virus without risking a serious disease response, reports BBC.
More Health
- BMI myth busted: Belly fat emerges as bigger threat to heart health
- 5 million lives lost: The heartbreaking truth about child deaths globally
- Study says global warming may make you less active — And it could be deadly
- Smoking fathers, sick kids? Study finds alarming diabetes link
- Australian techie turns to AI to develop personalised cancer vaccine for his dog, the result is surprising
-1763561110.jpg "Image of the day: November 19, 2025")
